The present invention provides a therapeutic composition for prevention or treatment of neurodegenerative brain disease caused by traumatic brain injury, comprising a regulator increasing expression or activity of calcineurin, and a screening method for a therapeutic agent for traumatic brain injury and neurodegenerative brain disease mediated by tau protein.